Melanoma risk calculator
QIMR Berghofer has unveiled the next-generation of its world-leading melanoma risk prediction calculator to better help Australians take action against one of the country’s most… Read More »Melanoma risk calculator
Before participating in a clinical trial, you should ensure you have spoken to your health professional to ensure this is the right path for you.
There are many types of clinical trials for melanoma and skin cancer patients, from using artificial intelligence to perform tasks or make predictions, to trialing a specific treatment option.
QIMR Berghofer has unveiled the next-generation of its world-leading melanoma risk prediction calculator to better help Australians take action against one of the country’s most… Read More »Melanoma risk calculator
MSCAN is proud to be part of the melanoma research led by QIMR Berghofer: testing whether receiving personalised genetic risk information can improve screening adherence… Read More »Q-Inform Trial
The recent Australian Centre of Excellence in Melanoma Imaging & Diagnosis (ACEMID) Community & Consumer forum in February 2025 provided an opportunity to share the… Read More »Early detection with 3d imaging
Congratulations to clever researchers at the National Health and Medical Research Council (NHMRC) Clinical Trials Centre at the University of Sydney who have won the… Read More »Award Winning Melanoma Researchers
One thing politicians from all sides of politics can agree on is the significant burden of skin cancer in Australia. That is why, wearing its… Read More »Parliamentary Friends of Melanoma & Skin Cancer Awareness
MSCAN asked Gabrielle Byars, CEO of Melanoma and Skin Cancer Trials (MASC Trials), to explain clinical trials and what they mean for melanoma and skin… Read More »Clinical trials for melanoma and skin cancer patients
MSCAN caught up with Prof H Peter Soyer, from The University of Queensland, to find out more about the Australian Centre of Excellence in Melanoma… Read More »Skin Cancer and Artificial Intelligence: The world’s largest imaging trial ever undertaken in skin cancer